Greenstone Biosciences
  • Home
  • About
    • About Us
    • Company
    • Our Team
    • Partners
  • Our Products
    hiPSC-Derived Cells
    • iPSC - Academia
    • Ventricular Cardiomyocytes
    • Atrial Cardiomyocytes
    • Fibroblasts
    • Smooth Muscle Cells
    • Macrophages
    • Endothelial Cells
    • Epithelial Cells
    Organoids
    • Ventricular Cardiac Organoid
    • Atrial Cardiac Organoid
    • Pancreatic Islet Organoid
    • Gut Organoid
    • Vascularized Ventricular Cardiac Organoid
    • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-Throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Functional assays of gut barrier Integrity and Disease Modelling.
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Publications (Partners)
    • SCR Publications (iPSC)
    • Webinars
    • News
    • Newsletter
    • LOS For Academic Researchers
    • Brochures
  • Investors
  • Careers
  • Quote
  • Contact
Login / Register
Search
0 Wishlist
0 items $0.00
Menu
0 items $0.00

Posts by admin

HomeArticles Posted by admin
20 Jun
Blog

Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery

  • June 23, 2026
  • By author-avatar admin
Combining human iPSC biology and AI computing to accelerate drug discovery, improve dru...

Continue reading

Joseph Wu
24 Apr
Blog

Joseph C. Wu elected to the American Academy of Arts and Sciences

  • April 30, 2026
  • By author-avatar admin
We are pleased to share that our co-founder,

Continue reading

09 Apr
Blog

SDDS 2026: Stanford Drug Discovery Symposium

  • May 17, 2026
  • By author-avatar admin
Consistency counts. We don’t just show up; we invest. Greenstone is back for our 4th s...

Continue reading

09 Apr
Blog

Greenstone Biosciences and Neolaia Bio Announce Strategic Collaboration Using iPSC-Derived Macrophages and Human Gut Organoids to Advance IBD Drug Development

  • April 9, 2026
  • By author-avatar admin
Greenstone Biosciences, a biotechnology company specializing in advanced human disease ...

Continue reading

09 Jan
Blog

Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences is a proud sponsor of the 2023 

Continue reading

27 Sep
Blog

Greenstone Biosciences Secures $2.75M to Advance Revolutionary Cardiotoxicity Detection Technology

  • February 23, 2026
  • By author-avatar admin
Published: Sep 13, 2023 PALO ALTO, CA — September 12, 2023 — Greenstone Biosc...

Continue reading

13 Jul
Blog

Congratulation to Greenstone Biosciences co-founder for becoming the President of American Heart Association

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences is excited to announce that our distinguished co-founder, Dr. Jo...

Continue reading

01 Feb
Blog

Greenstone Biosciences on a Quest for Duchenne Muscular Dystrophy Therapeutics with New Funding from CIRM

  • February 23, 2026
  • By author-avatar admin
Palo Alto, CA, February 1, 2023 – Recently, the California Institute of Regenerative Me...

Continue reading

12 Dec
Blog

Greenstone co-founder Joseph Wu inducted into NAI Class of 2022

  • February 23, 2026
  • By author-avatar admin
We want to congratulate our co-founder 

Continue reading

07 Dec
Blog

CIRM funds Greenstone Biosciences with $1.35M to accelerate drug discovery using patient – derived induced pluripotent stem cells

  • February 23, 2026
  • By author-avatar admin
Greenstone Biosciences, Inc., a computational biology driven drug discovery company,

Continue reading

  • 1
  • 2
Greenstone Biosciences

Greenstone Biosciences accelerates drug discovery through human-relevant NAMs and advanced AI technologies. By combining scientific expertise with innovative platforms, we deliver safer, more effective therapies to patients in less time.

Quick Links

  • Home
  • About Us
  • hiPSC-Derived Cells
  • Organoids
  • Services
  • Pipeline

Services

  • AI
  • Publications
  • News
  • Webinars
  • Corporate
  • Contact Us

Contact Us

  • (650)714-7060
  • info@greenstonebio.com
  • Stanford Research Park 3160 Porter Drive, Suite 140 Palo Alto, CA 94304
X-twitter Jki-linkedin-light Bluesky Streamline Icon: https://streamlinehq.com Bluesky

© 2026 Greenstone Biosciences, Inc. All rights reserved.

  • Privacy Policy
Start typing to see products you are looking for.
  • Menu
  • Categories
  • Accessories
  • Organoids
  • Electronics
  • Home
  • About
    • About Us
    • Company
    • Our Team
    • Partners
  • Our Products
    • hiPSC-Derived Cells
      • iPSC – Academia
      • Ventricular Cardiomyocytes
      • Atrial Cardiomyocytes
      • Fibroblasts
      • Smooth Muscle Cells
      • Macrophages
      • Endothelial Cells
      • Epithelial Cells
    • Organoids
      • Ventricular Cardiac Organoid
      • Atrial Cardiac Organoid
      • Pancreatic Islet Organoid
      • Gut Organoid
      • Vascularized Ventricular Cardiac Organoid
      • Vascularized Atrial Cardiac Organoid
  • Services
    • PBMC Collection and iPSC Reprogramming
    • Custom Differentiated iPSCs
    • Genetically Engineered iPSCs
    • High-throughput Drug Discovery
    • Cell Village
    • Clinical Trial in a Dish
    • CARTOX (hERG Toxicity Assay)
    • Hepatotoxicity Screen
    • Gut Organoid Permeability Assay
    • Pancreatic Islet Organoid – Glucose Sensitivity
  • Pipeline
  • AI
    • AI
    • Admet Ai
  • Resources
    • Publications
    • Publications (Partners)
    • SCR Publications (iPSC)
    • Webinars
    • News
    • Newsletter
    • LOS For Academic Researchers
    • Brochures
  • Investors
  • Careers
  • Contact us
  • Wishlist
  • Compare
  • Login / Register
Shopping cart
Close
Sign in
Close

Lost your password?

No account yet?

Create an Account